Türei, Dénes https://orcid.org/0000-0002-7249-9379
Valdeolivas, Alberto https://orcid.org/0000-0001-5482-9023
Gul, Lejla
Palacio‐Escat, Nicolàs https://orcid.org/0000-0002-7022-1437
Klein, Michal https://orcid.org/0000-0002-2433-6380
Ivanova, Olga https://orcid.org/0000-0002-9111-4593
Ölbei, Márton https://orcid.org/0000-0002-4903-6237
Gábor, Attila https://orcid.org/0000-0002-0776-1182
Theis, Fabian https://orcid.org/0000-0002-2419-1943
Módos, Dezső https://orcid.org/0000-0001-9412-6867
Korcsmáros, Tamás https://orcid.org/0000-0003-1717-996X
Saez‐Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Funding for this research was provided by:
JRC COMBINE, partially funded by Bayer AG
European Union Innovative Medicines Initiative TransQST (116030)
Federal Ministry of Education (031L0181B)
Deutsche Forschungsgemeinschaft (SA 3554/1‐2)
UKRI|Biotechnology and Biological Sciences Research Council (BB/J004529/1)
UKRI|Biotechnology and Biological Sciences Research Council (BB/P016774/1)
UKRI|Biotechnology and Biological Sciences Research Council (BB/CSP17270/1)
UK Research and Innovation|Biotechnology and Biological Sciences Research Council, ISP grant for Gut Microbes and Health (BB/R012490/1)
UK Research and Innovation|Biotechnology and Biological Sciences Research Council, Norwich Research Park Biosciences Doctoral Training Partnership grant (BB/M011216/1)
Article History
Received: 14 August 2020
Revised: 11 February 2021
Accepted: 15 February 2021
First Online: 22 March 2021
Conflict of interest
: JSR receives funding from GSK and Sanofi and consultant fees from Travere Therapeutics.